Collegium Pharmaceutical (COLL) Depreciation & Amortization (CF) (2016 - 2026)
Collegium Pharmaceutical has reported Depreciation & Amortization (CF) over the past 10 years, most recently at $923000.0 for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) fell 11.34% year-over-year to $923000.0; the TTM value through Dec 2025 reached $4.2 million, up 8.45%, while the annual FY2025 figure was $4.2 million, 8.45% up from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 was $923000.0 at Collegium Pharmaceutical, down from $1.0 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $1.1 million in Q2 2025 and troughed at $424000.0 in Q4 2021.
- A 5-year average of $797700.0 and a median of $865000.0 in 2023 define the central range for Depreciation & Amortization (CF).
- Biggest five-year swings in Depreciation & Amortization (CF): surged 129.74% in 2021 and later decreased 11.34% in 2025.
- Year by year, Depreciation & Amortization (CF) stood at $424000.0 in 2021, then soared by 94.58% to $825000.0 in 2022, then increased by 15.03% to $949000.0 in 2023, then increased by 9.69% to $1.0 million in 2024, then decreased by 11.34% to $923000.0 in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for COLL at $923000.0 in Q4 2025, $1.0 million in Q3 2025, and $1.1 million in Q2 2025.